Senzo Health Limited (London, UK) ("Senzo"), a life sciences company developing high-accuracy, low-cost, point-of-care diagnostic technologies, this week announced an additional $1.8m investment for its breakthrough Amplified Lateral Flow (ALF) test technology, advancing its mission to bring high-quality, affordable tests into the home.

Abingdon Health's CDMO service to support Senzo in leveraging its innovative, high-accuracy Amplified Lateral Flow (ALF) point-of-care diagnostics platform technology across multiple product opportunities.

The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified Lateral Flow (ALF) platform returned greater than 98% accuracy against PCR, including in low viral-load samples

The Tiny, Portable, and Economical Mini 16™ Ultra-Fast Portable qPCR Machine is designed for Point-of-Care Testing, Research, and Veterinary Applications

As new mutations of SARS-CoV-2 keep spreading worldwide, Hyris keeps monitoring its test kits effectiveness, performing routine analysis of SARS-CoV-2 variants to safeguard public health and the product's quality by assessing the potential impact of new strains on sensitivity and specificity.

OliLux Biosciences will expand its research and clinical operations to develop diagnostic and treatment monitoring tools for the rapid detection and management of tuberculosis.

Given the possibility that an employee can have COVID-19 but be asymptomatic and unknowingly spread the virus to others, TopLab's ability to provide employers with critical and potentially life-saving information concerning the presence of infection among their workforce enables them to best protect their entire organization.

Future Outlook: Point of Care (POC) Diagnostics Market to Offer Significant Growth Opportunities

The new offerings are aimed at automating payer operations around clinical integration & physician engagement for enhanced Star Ratings

Researchers from Ram Group's Israeli team developed a breakthrough in molecular diagnostic sensors detecting cancer early before metastasis

Ram Group Aims to Introduce Revolutionary Low-Cost Point-of-Care Diagnostics and Healthcare Monitoring Devices to Low-Income Communities.

GrandViewResearch.com has announced the addition of " Asia Pacific PoC (Point of care) Diagnostics Market Analysis And Segment Forecasts To 2020" Market Research report to their Database.